A review on quality of life in keratinocyte carcinoma patients

Giornale Italiano di Dermatologia e Venereologia

Volumn 148, Issue 3, 2013, Pages 249-254

  Waalboer Spuij, R ^a   Nijsten, T E C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Carcinoma, basal cell; Carcinoma, squamous cell; Outcome assessment, health care; Quality of life

Indexed keywords

ACTINIC KERATOSIS; CANCER PATIENT; CANCER THERAPY; CLINICAL ASSESSMENT TOOL; COPING BEHAVIOR; DAILY LIFE ACTIVITY; HUMAN; KERATINOCYTE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SKIN CANCER; SKIN CARCINOMA; SYSTEMATIC REVIEW;

EID: 84879776699     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Flohil SC, de Vries E, Neumann HA, Coebergh JW, Nijsten T. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011;91:24-30.
2. Flohil SC, Seubring I, van Rossum MM, Coebergh JW, de Vries E, Nijsten T. Trends in Basal Cell Carcinoma Incidence Rates: A 37-Year Dutch Observational Study. J Invest Dermatol 2013;133:913-8.
3. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer 2012;48:2046-53.
4. Cornish D, Holterhues C, van de Poll-Franse LV, Coebergh JW, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009;20(Suppl 6):vi51-8.
5. van der Geer S, Reijers HA, van Tuijl HF, de Vries H, Krekels GA. Need for a new skin cancer management strategy. Arch Dermatol 2010;146:332-6.
6. Weinstock MA, Lee KC, Chren MM, Marcolivio K. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol 2009;61:207-15.
7. Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 1996;5:191-4. (Pubitemid 26180666)
8. Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M. Quality of life assessment in nonmelanoma cervicofacial skin cancer. Laryngoscope 2003;113:215-20. (Pubitemid 36176983)
9. Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB. Quality of Life and Sun-Protective Behavior in Patients with Skin Cancer. Arch Otolaryngol Head Neck Surg 2004;130:141-6. (Pubitemid 38182537)
10. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997;108:103-7. (Pubitemid 27019854)
11. Roberts N, Czajkowska Z, Radiotis G, Korner A. Distress and Coping Strategies Among Patients with Skin Cancer. J Clin Psychol Med Settings 2012 [Epub ahead of print].
12. Steinbauer J, Koller M, Kohl E, Karrer S, Landthaler M, Szeimies RM. Quality of life in health care of non-melanoma skin cancer - Results of a pilot study. JDDG J German Soc Dermatol 2011;9:129-35.
13. Rhee JS, Matthews BA, Neuburg M, Smith TL, Burzynski M, Nattinger AB. Skin Cancer and Quality of Life: Assessment with the Dermatology Life Quality Index. Dermatol Surg 2004;30:525-9. (Pubitemid 38529593)
14. Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. The skin cancer index: Clinical responsiveness and predictors of quality of life. Laryngoscope 2007;117:399-405. (Pubitemid 46407744)
15. Moloney FJ, Keane S, O'Kelly P, Conlon PJ, Murphy GM. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005;153:574-8. (Pubitemid 41248215)
16. Lee KC, Weinstock MA, Veterans Affairs Topical Tretinoin Chemoprevention Trial G. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial. J Am Acad Dermatol 2010;63:1107-9.
17. Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2007;127:1351-7. (Pubitemid 46762993)
18. Chen T, Bertenthal D, Sahay A, Sen S, Chren MM. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007;143:1386-92. (Pubitemid 350146265)
19. Chren MM. The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life. Dermatol Clin 2012;30:231-6.
20. Sampogna F SA, Di Pietro C, Pagliarello C, Paradisi A, Tabolli S, Abeni D. Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients. J Invest Dermatol 2013;133:104-9.
21. Rhee JS, Matthews BA, Neuburg M, Burzynski M, Nattinger AB. Creation of a quality of life instrument for nonmelanoma skin cancer patients. Laryngoscope 2005;115:1178-85. (Pubitemid 40962352)
22. Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg 2006;32:924-34; discussion 34.
23. Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg 2006;8:314-8. (Pubitemid 44497417)
24. Caddick J, Green L, Stephenson J, Spyrou G. The psycho-social impact of facial skin cancers. J Plast Reconstr Aesthet Surg 2012;65:e257-9.
25. Burdon-Jones D, Thomas P, Baker R. Quality of life issues in non-metastatic skin cancer. Br J Dermatol 2010;162:147-51.
26. Burdon-Jones D, Gibbons K. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): A validated health-related quality of life questionnaire for non-metastatic skin cancers. J Eur Acad Dermatol Venereol 2012 [Epub ahead of print].
27. Esmann S, Vinding GR, Christensen KB, Jemec GBE. Assessing the influence of Actinic Keratosis on Patients' Quality of Life - The AKQoL Questionnaire. Br J Dermatol 2013;168:277-83.
28. Nijsten T, de Haas ER, Neumann MH. Question the obvious. Arch Dermatol 2007;143:1429-32. (Pubitemid 350146271)
29. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007;127:2726-39. (Pubitemid 350134835)